The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)
暂无分享,去创建一个
[1] Daniel J. Klionsky,et al. Autophagy fights disease through cellular self-digestion , 2008, Nature.
[2] C. Angelini,et al. Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency , 2008, Neurology.
[3] P. Dean,et al. X‐Linked myopathy with excessive autophagy: A new hereditary muscle disease , 1988, Annals of neurology.
[4] E. Ralston,et al. When more is less: Excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease , 2009, Autophagy.
[5] A. Salminen,et al. Regulation of the aging process by autophagy. , 2009, Trends in molecular medicine.
[6] E. Ralston,et al. Fiber Type Conversion by PGC-1α Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal Muscle , 2010, PloS one.
[7] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[8] S. Marie,et al. Deconstructing Pompe Disease by Analyzing Single Muscle Fibers: “To See a World in a Grain of Sand…” , 2007, Autophagy.
[9] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[10] J. Rilstone,et al. RETRACTED: VMA21 Deficiency Causes an Autophagic Myopathy by Compromising V-ATPase Activity and Lysosomal Acidification , 2009, Cell.
[11] S. Tsujino,et al. [Acid maltase deficiency]. , 2001, Ryoikibetsu shokogun shirizu.
[12] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[13] D. Metzger,et al. Autophagy is required to maintain muscle mass. , 2009, Cell metabolism.
[14] N. Raben,et al. The values and limits of an in vitro model of Pompe disease: The best laid schemes o’ mice an’ men ……..† , 2009, Autophagy.
[15] W. Stauber,et al. Inhibition of lysosomal function in red and white skeletal muscles by chloroquine , 1981, Experimental Neurology.
[16] M. Komatsu,et al. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe disease , 2010, Autophagy.
[17] S. Dimauro,et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) , 2000, Nature.
[18] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] Y. Chien,et al. Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early Treatment , 2009, Pediatrics.
[20] V. Hill,et al. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. , 2008, Human molecular genetics.
[21] A. Russell,et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.